Okla. Stat. tit. 63, § 63-1-556

A. The State Department of Health, giving consideration to the

recommendations of the Advancement of Wellness Advisory Council

created in Section 1-103a.1 of this title, shall be responsible for

evaluating and reporting to the Governor and the State Commissioner

of Health regarding contracting for statewide services or issues

related to breast cancer including, but not limited to:

1. Mammography and pap smear screening of women for breast and

cervical cancer as an early detection health care measure provided

by facilities which are accredited by national organizations that

have formed coalitions to issue national cancer screening

guidelines;

2. Medical referral of screened persons with abnormal breast

findings and, to the extent practical, for additional services or

assistance for such persons;

3. Education and training programs for health care

professionals to improve methods for the detection and control of

breast and cervical cancer, and to improve communication with breast

and cervical cancer patients after diagnosis;

Oklahoma Statutes - Title 63. Public Health and Safety Page 250

4. Annual public education and awareness campaigns to improve

the knowledge and health care practices of all Oklahomans with

respect to breast and cervical cancer;

5. Epidemiological trend studies utilizing the data from the

Oklahoma Central Cancer Registry for incidence, prevalence and

survival of breast and cervical cancer victims; and

6. Outreach to groups with high proportions of uninsured and

underinsured women.

B. The evaluative efforts of the Advisory Committee with

respect to contracts for services specified in subsection A of this

section shall provide appropriate oversight and requirements that

result in:

1. Enhanced quality control standards within facilities which

perform diagnostic cancer screening for breast and cervical cancer;

and

2. Establishment of a fee schedule for breast and cervical

cancer screening and diagnosis that complies with accepted

Medicare/Medicaid rates and that incorporates a sliding fee payment

system to encourage self-responsibility.

C. The State Department of Health, giving consideration to the

recommendations of the Advancement of Wellness Advisory Council

created in Section 1-103a.1 of this title, shall report to the

Governor, the Speaker of the House of Representatives, the President

Pro Tempore of the Senate, and the State Commissioner of Health by

October 1 of every fifth year, beginning on October 1, 2021,

activities completed pursuant to the Oklahoma Breast and Cervical

Cancer Act during the prior five (5) fiscal years including a report

of the revolving funds expended on related activities. The report

may identify populations at highest risk for breast or cervical

cancer, priority strategies, and emerging technologies including

newly introduced therapies and preventive vaccines that are

effective in preventing and controlling the risk of breast and

cervical cancer, and any recommendations for additional funding, if

necessary, to provide screenings and treatment for breast and

cervical cancer for uninsured and underinsured women. The report

may further recommend strategies or actions to reduce the costs of

breast and cervical cancer in this state.

D. The Advancement of Wellness Advisory Council shall evaluate

the prospective termination or continuation of its ongoing duties on

October 1, 2008. Such evaluation shall be made based on the

successful implementation of breast and cervical cancer reduction

plans and/or achievement of significant reductions in breast and

cervical cancer morbidity and mortality in this state.